| (Values in U.S. Thousands) | Jun, 2019 | Mar, 2019 | Dec, 2018 | Sep, 2018 | Jun, 2018 |
| Sales | 12,350 | 11,130 | 10,890 | 14,220 | 13,150 |
| Sales Growth | +10.96% | +2.20% | -23.42% | +8.14% | +24.41% |
| Net Income | -11,150 | -14,770 | -12,850 | -12,970 | -11,780 |
| Net Income Growth | +24.51% | -14.94% | +0.93% | -10.10% | -11.87% |
Nuvectra Corp (NVTR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Nuvectra Corporation develops and commercializes neuromodulation medical device for the treatment of nervous system disorders. It also provides neural interface technology, components and systems, as well as NeuroNexus SmartBox portable control and data streaming systems. Nuvectra Corporation is based in Plano, Texas.